Integre Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Integre Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-23,860	Closed	-$2.56M	–	150
2016 Q4	$2.56M	Buy	23,860 +266	+1%	+$31.1K	0.83%	44
2016 Q3	$2.94M	Sell	23,594 -11	-0%	-$1.3K	0.91%	43
2016 Q2	$2.51M	Hold	23,605	–	–	0.87%	41
2016 Q1	$2.7M	Sell	23,605 -2,071	-8%	-$243K	0.81%	36
2015 Q4	$3.66M	Buy	25,676 +148	+0.6%	+$17.1K	0.87%	36
2015 Q3	$2.29M	Sell	25,528 -334	-1%	-$35.3K	0.55%	42
2015 Q2	$2.98M	Sell	25,862 -3,259	-11%	-$342K	0.62%	41
2015 Q1	$2.78M	Buy	+29,121	New	+$2.18M	0.55%	43

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Integre Asset Management's CBPO Position: Q1 2017 in Review

Integre Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 23,860 shares — an estimated $2.56M sold.

Integre Asset Management first reported a position in CBPO in Q1 2015 and held it in 8 quarters. The position peaked at $3.66M in Q4 2015. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

Integre Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Integre Asset Management sold 23,860 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $2.56M.
Integre Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2015 and held it in 8 quarters.
Integre Asset Management's China Biologic Products Holdings, Inc. position peaked at $3.66M in Q4 2015.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Integre Asset Management's 13F filing for Q1 2017, filed 15 May 2017.